NasdaqGS - Nasdaq Real Time Price USD

Trinity Biotech plc (TRIB)

1.8400

+0.0100

(+0.55%)

As of 11:23 AM EDT. Market Open.

Trinity Biotech plc (NASDAQ:TRIB) Q4 2023 Earnings Call Transcript

Trinity Biotech plc (NASDAQ:TRIB) Q4 2023 Earnings Call Transcript April 4, 202 Trinity Biotech plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings! Welcome to the Trinity Biotech’s Fourth Quarter and Full Year 2023 Earnings Conference Call. At this […]

Insider Monkey 18 days ago

TRIB
+0.55%
Trinity Biotech PLC (TRIB) Q4 2023 Earnings Call Transcript Highlights: A Glimpse into ...

Trinity Biotech reveals Q4 results and strategic initiatives amidst a challenging fiscal year, setting the stage for a transformative 2024.

GuruFocus.com 20 days ago

TRIB
+0.55%
Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates

DUBLIN, Ireland, April 04, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, today announced results for the quarter ended December 31, 2023 and fiscal year 2023 and key business updates. Business Updates Comprehensive Transformation Plan At the Emerging Growth Investor Conference on March 7, 2024, our new management team announced a comprehensive tra

GlobeNewswire 22 days ago

TRIB
+0.55%
Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results

Conference Call Scheduled for Thursday, April 4, 2024 at 8:00 AM ETDUBLIN, Ireland, March 28, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, will report financial results for the fourth quarter and fiscal year 2023 on Thursday, April 4, 2024 at 8:00 AM ET. Conference Call Dial-In & Webcast Information Date:Thursday, April 4, 2024Time:8:00 AM ETUnited S

GlobeNewswire 28 days ago

TRIB
+0.55%
Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

DUBLIN, Ireland, March 08, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc. (NASDAQ: TRIB) (the “Company”) today reported the receipt of a formal notification from The Nasdaq Stock Market LLC ("Nasdaq") that the Company has regained compliance with Listing Rule 5450(a)(1), which requires the Company's American Depositary Shares (“ADSs”) to maintain a minimum bid price of $1.00 per ADS. The Nasdaq staff made this determination of compliance after the closing bid price of the Company's was at $1.00 p

GlobeNewswire last month

TRIB
+0.55%
Presenting on the Emerging Growth Conference 68 Day 2 on March 7 Register Now

MIAMI, March 06, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 68th Emerging Growth Conference on March 6 & 7, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting compani

GlobeNewswire last month

GTRIF

FDXTF

ARWYF
Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change

DUBLIN, Ireland, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc.(NASDAQ: TRIB) (the “Company”) today announced that it has finalized the effective date of its ratio change of its American depositary shares (“ADSs”) from one (1) ADS representing four (4) Class A ordinary shares to one (1) ADS representing twenty (20) Class A ordinary shares. The effect of the ratio change on the ADS trading price on the Nasdaq Global Market is expected to take place at the open of trading on February 23, 2

GlobeNewswire 2 months ago

TRIB
+0.55%
Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change

DUBLIN, Ireland, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc.(NASDAQ: TRIB) (the “Company”) today announced that it plans to change the ratio of the American depositary shares (“ADSs”) representing its Class A ordinary shares from one (1) ADS representing four (4) Class A ordinary share to one (1) ADS representing twenty (20) Class A ordinary shares. For Trinity Biotech Plc ADS holders, the change in the ADS ratio will have the same effect as a one-for-five reverse ADS split and is int

GlobeNewswire 2 months ago

TRIB
+0.55%
Trinity Biotech to Present at Emerging Growth Conference

DUBLIN, Ireland, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), today announces that management will present virtually at the Emerging Growth Conference on March 7, 2024. The Company invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference. Please see the presentation information below. Presentation Details Date:Thursday, March 7, 2024Time:11:25 – 11:

GlobeNewswire 2 months ago

TRIB
+0.55%
Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA Code

DUBLIN, Ireland, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc. (Nasdaq: TRIB) (the “Company”) today announced that its New York based reference laboratory, Immco Diagnostics, has applied for a Proprietary Laboratory Analyses (PLA) code for its Early Sjögrens Syndrome Test Panel, to allow for an optimised market access strategy to deliver broader patient access and improved profitability. It is estimated that up to approximately 3 million people in the US have Sjögrens Syndrome, making i

GlobeNewswire 2 months ago

TRIB
+0.55%
Trinity Biotech Third Quarter 2023 Earnings: US$0.17 loss per share (vs US$0.23 loss in 3Q 2022)

Trinity Biotech ( NASDAQ:TRIB ) Third Quarter 2023 Results Key Financial Results Revenue: US$14.7m (down 25% from 3Q...

Simply Wall St. 2 months ago

TRIB
+0.55%
Trinity Biotech (TRIB) to Grow in Wearable Biosensor With Buyout

Trinity Biotech's (TRIB) focus on CGM as an initial step, utilizing a device with regulatory approval, provides a de-risked entry point in the wearable biosensor technology space.

Zacks 2 months ago

TRIB
+0.55%
HAE

DVA
Trinity Biotech Announces Q3 2023 Financial Results & Business Update

-Investor call to be held today at 8:30 am ESTDUBLIN, Ireland, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) today announced the Company’s results for the quarter ended September 30, 2023. Business Updates and Strategic Priorities In December 2023, the Company announced the promotion of John Gillard from CFO to CEO and the promotion of Des Fitzgerald to the role of Interim CFO. The new management team has now put in place a clear set of strategies and priorities as set out

GlobeNewswire 2 months ago

TRIB
+0.55%
Trinity Biotech Announces Entry into a Letter of Intent with Bayer for a Joint Partnership to Launch a CGM Biosensor Device in China and India

DUBLIN, Ireland, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”) today announced that it has entered into a non-binding Letter of Intent with Bayer for the launch of a Continuous Glucose Monitoring (“CGM”) biosensor device in China and India. This Letter of Intent is related to the Company’s recently announced acquisition of the CGM assets of Waveform Technologies, Inc. Trinity has entered into a Letter of Intent with Bayer’s subsidiary in China under which b

GlobeNewswire 2 months ago

TRIB
+0.55%
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.

-Repositioning to a rapidly expanding biosensor market with potential for significant growth for the company as part of a revised strategy under our new management -Upfront payment of $12.5 million cash and 9 million ADSs -Strengthened investment relationship with Perceptive Advisors with the entry into an increased senior secured term loan credit facility with lower interest rates and Perceptive Advisors taking an approximately 20% equity interest in Trinity -Investor call to be held today at 8

GlobeNewswire 2 months ago

TRIB
+0.55%
Trinity Biotech plc to Host Investor Call

Conference Call Scheduled for Wednesday, January 31, 2024 at 8:30 AM ETDUBLIN, Ireland, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, will host an investor call on Wednesday, January 31 at 8:30 AM ET to provide an update on business operations. Conference Call Dial-In & Webcast Information Date:Wednesday, January 31, 2024Time:8:30 AM ETUnited

GlobeNewswire 2 months ago

TRIB
+0.55%
Trinity Biotech Announces It Has Begun Shipments of Its New HIV Screening Test, TrinScreen HIV to Kenya

DUBLIN, Ireland, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announces it has begun commercial shipments to Kenya of its new rapid HIV screening test, TrinScreen HIV. The Kenyan HIV screening programme is one of the largest in Africa, with an estimated 10 million HIV screening tests performed annually. The Company has begun commercial

GlobeNewswire 3 months ago

TRIB
+0.55%
Trinity Biotech Announces Management Changes

John Gillard Named Chief Executive OfficerDes Fitzgerald Named Interim Chief Financial Officer DUBLIN, Ireland, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the promotion of John Gillard, our Chief Financial Officer, to President and Chief Executive Officer, effective immediately. Des Fitzgerald, who has served as Director of

GlobeNewswire 4 months ago

TRIB
+0.55%
Trinity Biotech plc (NASDAQ:TRIB) Held Back By Insufficient Growth Even After Shares Climb 31%

Those holding Trinity Biotech plc ( NASDAQ:TRIB ) shares would be relieved that the share price has rebounded 31% in...

Simply Wall St. 4 months ago

TRIB
+0.55%
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares

DUBLIN, Ireland, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, today announced that on November 21, 2023 the Company received notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) that the Company is not in compliance with the minimum market value of publicly held shares ("MVPHS") requirement set forth in the Nasdaq Listing Rules.

GlobeNewswire 4 months ago

TRIB
+0.55%

Performance Overview

Return	TRIB	MSCI WORLD
YTD	-14.42%	+5.14%
1-Year	-64.62%	+19.45%
3-Year	-89.75%	0.00%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Trinity Biotech plc (TRIB)

Trinity Biotech plc (NASDAQ:TRIB) Q4 2023 Earnings Call Transcript

Trinity Biotech PLC (TRIB) Q4 2023 Earnings Call Transcript Highlights: A Glimpse into ...

Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates

Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results

Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

Presenting on the Emerging Growth Conference 68 Day 2 on March 7 Register Now

Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change

Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change

Trinity Biotech to Present at Emerging Growth Conference

Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA Code

Trinity Biotech Third Quarter 2023 Earnings: US$0.17 loss per share (vs US$0.23 loss in 3Q 2022)

Trinity Biotech (TRIB) to Grow in Wearable Biosensor With Buyout

Trinity Biotech Announces Q3 2023 Financial Results & Business Update

Trinity Biotech Announces Entry into a Letter of Intent with Bayer for a Joint Partnership to Launch a CGM Biosensor Device in China and India

Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.

Trinity Biotech plc to Host Investor Call

Trinity Biotech Announces It Has Begun Shipments of Its New HIV Screening Test, TrinScreen HIV to Kenya

Trinity Biotech Announces Management Changes

Trinity Biotech plc (NASDAQ:TRIB) Held Back By Insufficient Growth Even After Shares Climb 31%

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares

Performance Overview